Albemarle Corp buy BMO Capital Markets
Start price
07.11.23
/
50%
€114.90
Target price
07.11.24
€168.34
Performance (%)
4.22%
Price
03.05.24
€119.02
Summary
This prediction is currently active. With a performance of 4.22%, the BUY prediction by BMO_Capital_Markets for Albemarle Corp is trending in the right direction. A total of €0.73 was paid as dividends for this prediction. This prediction currently runs until 07.11.24. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionAlbemarle is a specialty chemical company that produces and markets lithium, bromine, and other specialty chemicals globally. The company's products are used in a wide range of applications, including energy storage, flame retardants, pharmaceuticals, and agricultural solutions. Albemarle's lithium business has been a key driver of growth in recent years due to increasing demand for lithium-ion batteries used in electric vehicles and other technologies. The company has a market capitalization of around $11 billion and is listed on the New York Stock Exchange under the ticker symbol ALB.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Albemarle Corp | 8.973% | 8.973% |
| iShares Core DAX® | -0.922% | -1.993% |
| iShares Nasdaq 100 | 0.371% | -0.868% |
| iShares Nikkei 225® | 2.224% | -5.187% |
| iShares S&P 500 | -0.026% | -0.918% |
Comments by BMO_Capital_Markets for this prediction
In the thread Albemarle Corp diskutieren
Albemarle Co. (NYSE: ALB) had its price target lowered by analysts at BMO Capital Markets from $265.00 to $180.00. They now have an "outperform" rating on the stock.
Ratings data for ALB provided by MarketBeat